Nexperia Issues Update on Governance, Supply Chain Stability, and Recent Developments in China
Geopolitical Developments and Supply Chain Status
Nexperia welcomes the recent decision by Chinese authorities to allow its factories and subcontractors in China to resume certain export activities. While this represents positive movement, it is important to clarify that the authorization is granted through exemptions and does not constitute a full restoration of the supply chain.
Compliance With Dutch Government Orders
Nexperia is aware of speculation in the media regarding the status of the Dutch government order.
The company confirms that it has not received any official communication from the Dutch Ministry of Economic Affairs regarding the lifting or modification of the order.
Nexperia continues to fully comply with all directives issued by the Dutch government.
Clarification on the Enterprise Chamber Ruling and CEO Status
It is essential to distinguish between the Enterprise Chamber’s ruling and the Dutch government’s order—these are two separate and unrelated legal matters. The Enterprise Chamber is a specialized division of the Amsterdam Court of Appeal.
Nexperia has noted rumors suggesting that Xuezheng (Wing) Zhang has resumed his position as CEO. The company reiterates that, according to the Enterprise Chamber’s judgment dated 7 October 2025, Zhang remains suspended and is no longer serving as Nexperia’s CEO.
Furthermore, the Enterprise Chamber has assigned the voting rights of nearly all Nexperia shares indirectly held by Wingtech Technology Co., Ltd. (“Wingtech”) to an independent administrator appointed by the court.
Supply Chain Resilience
Nexperia firmly states that it has not halted wafer deliveries. The company remains committed to supplying wafers into the value chain and continues to provide alternative logistics and delivery solutions wherever possible to minimize disruption.
In practice, this includes direct sales and shipments of wafers to Nexperia customers.
Dedicated teams are actively working to implement and maintain these temporary arrangements until the full turnkey supply chain is restored. All other Nexperia manufacturing sites—across Europe and the rest of Asia—are operating as normal. Meanwhile, capacity expansion at additional facilities is being accelerated, with phased deployment expected in 2026.
Operational Disruptions in China
Nexperia also reports that its China-based entities are no longer operating under the company’s established governance framework and have disregarded lawful instructions from Nexperia BV’s global management. This includes:
• Refusal to pay for wafers supplied
• Unauthorized use of corporate seals without valid justification
• Establishment of unapproved bank accounts and instructions directing customers to use them
• Issuing unauthorized communications to customers, subcontractors, suppliers, and employees containing misleading information
Despite these actions, Nexperia continued direct wafer shipments throughout October 2025, even after Chinese export restrictions took effect. Based on the company’s internal controls—specifically the required minimum inventory levels and the volume of wafers shipped during this period—Nexperia believes that its China operations should have sufficient wafer and finished goods inventory to sustain operations for several months.
Any claims suggesting otherwise cast significant doubt on the inventory management practices of the local management team in China. Accordingly, any failure to meet shipment commitments is solely the responsibility of the China-based entities.